Thomas J. Carella - Net Worth and Insider Trading

Thomas J. Carella Net Worth

The estimated net worth of Thomas J. Carella is at least $24,221 dollars as of 2024-11-13. Thomas J. Carella is the Director of T2 Biosystems Inc and owns about 41,572 shares of T2 Biosystems Inc (TTOO) stock worth over $23,243. Thomas J. Carella is also the Director of Openlane Inc and owns about 49 shares of Openlane Inc (KAR) stock worth over $979. Details can be seen in Thomas J. Carella's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas J. Carella has not made any transactions after 2015-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Thomas J. Carella

To

Thomas J. Carella Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas J. Carella owns 6 companies in total, including Outset Medical Inc (OM) , T2 Biosystems Inc (TTOO) , and Openlane Inc (KAR) among others .

Click here to see the complete history of Thomas J. Carella’s form 4 insider trades.

Insider Ownership Summary of Thomas J. Carella

Ticker Comapny Transaction Date Type of Owner
OM Outset Medical Inc 2020-09-14 director
TTOO T2 Biosystems Inc 2015-12-09 director
KAR Openlane Inc 2013-11-13 director
LIMIT LIMIT 2020-10-30 director
LIMIT LIMIT 2021-03-26 director
LIMIT LIMIT 2020-10-30 director

Thomas J. Carella Latest Holdings Summary

Thomas J. Carella currently owns a total of 2 stocks. Among these stocks, Thomas J. Carella owns 41,572 shares of T2 Biosystems Inc (TTOO) as of December 9, 2015, with a value of $23,243 and a weighting of 95.96%. Thomas J. Carella also owns 49 shares of Openlane Inc (KAR) as of November 13, 2013, with a value of $979 and a weighting of 4.04%.

Latest Holdings of Thomas J. Carella

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TTOO T2 Biosystems Inc 2015-12-09 41,572 0.56 23,243
KAR Openlane Inc 2013-11-13 49 19.97 979

Holding Weightings of Thomas J. Carella


Thomas J. Carella Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas J. Carella has made a total of 0 transactions in T2 Biosystems Inc (TTOO) over the past 5 years. The most-recent trade in T2 Biosystems Inc is the acquisition of 7,000 shares on December 9, 2015, which cost Thomas J. Carella around $7 Million.

According to the SEC Form 4 filings, Thomas J. Carella has made a total of 0 transactions in Openlane Inc (KAR) over the past 5 years. The most-recent trade in Openlane Inc is the sale of 7,116,476 shares on November 13, 2013, which brought Thomas J. Carella around $193 Million.

Insider Trading History of Thomas J. Carella

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas J. Carella Trading Performance

GuruFocus tracks the stock performance after each of Thomas J. Carella's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas J. Carella is -2.83%. GuruFocus also compares Thomas J. Carella's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas J. Carella within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Thomas J. Carella's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Thomas J. Carella

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.63 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.76 LIMIT LIMIT LIMIT LIMIT LIMIT

Thomas J. Carella Ownership Network

Ownership Network List of Thomas J. Carella

No Data

Ownership Network Relation of Thomas J. Carella

Insider Network Chart

Thomas J. Carella Owned Company Details

What does Outset Medical Inc do?

Who are the key executives at Outset Medical Inc?

Thomas J. Carella is the director of Outset Medical Inc. Other key executives at Outset Medical Inc include director & President & CEO Leslie Trigg , SVP & Operations and R&D Marc Nash , and Interim CFO Nabeel Ahmed .

Outset Medical Inc (OM) Insider Trades Summary

Over the past 18 months, Thomas J. Carella made no insider transaction in Outset Medical Inc (OM). Other recent insider transactions involving Outset Medical Inc (OM) include a net sale of 34,566 shares made by Nabeel Ahmed , a net sale of 107,344 shares made by Leslie Trigg , and a net sale of 38,408 shares made by John L. Brottem .

In summary, during the past 3 months, insiders sold 13,583 shares of Outset Medical Inc (OM) in total and bought 0 shares, with a net sale of 13,583 shares. During the past 18 months, 266,328 shares of Outset Medical Inc (OM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 266,328 shares.

Outset Medical Inc (OM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Outset Medical Inc Insider Transactions

No Available Data

Thomas J. Carella Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas J. Carella. You might contact Thomas J. Carella via mailing address: C/o Goldman, Sachs & Co., 85 Broad Street, New York Ny 10004.